Clinical trial
Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Diffusion Capacity Defect by REGEND001 Cell Therapy
NCT05638776
Study timeline
Study start (actual)2022-12-06Date precision: day
Registry last updated2026-09-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Chronic Obstructive Pulmonary Diseaseunresolved
Interventions
PlaceboDRUG
Sponsors & collaborators
Regend Therapeuticslead sponsor
Southwest Hospital, Chinacollaborator
Shanghai Zhongshan Hospitalcollaborator
China-Japan Friendship Hospitalcollaborator
Shanghai East Hospitalcollaborator
Regend Therapeutics XLotus (Jiangxi) Co, Ltd.collaborator
Xiangya Hospital of Central South Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05638776 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.